Syringe News and Research

RSS

Study shows how stomach bacteria manipulates human immune system to survive in stomach

Helicobacter pylori is a bacterium that establishes a life-long stomach infection in humans, which in some cases can lead to duodenal ulcers or stomach cancer. New research, presented at this week's Society for General Microbiology Autumn Conference, gives us a clearer understanding of how these bacteria can manipulate the human immune system to survive in the mucosal lining of the stomach.

4 Sep 2013

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

OxyContin contains oxycodone, which is an opioid agonist. It is used for the management of moderate to severe pain when a constant opioid analgesic is needed for a prolonged period of time.

29 Aug 2013

Smartphone-based portable device to conduct kidney tests invented at UCLA

A lightweight and field-portable device invented at UCLA that conducts kidney tests and transmits data through a smartphone attachment may significantly reduce the need for frequent office visits by people with diabetes and others with chronic kidney ailments.

26 Aug 2013

CSL Biotherapies starts shipment of seasonal influenza vaccine for 2013-2014 season

CSL Biotherapies, Inc. announced today that shipment of its seasonal influenza vaccine for the 2013-2014 season has started.

7 Aug 2013

Scientists solve structure of infection tool used by Yersinia bacterium

Abdominal pain, fever, diarrhoea -- these symptoms could point to an infection with the bacterium Yersinia. The bacterium's pathogenic potential is based on a syringe-like injection apparatus called injectisome.

1 Aug 2013

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Essentially, what an artificial pancreas would be doing is taking the blood glucose results from a continuous monitor and taking the data that the patient puts in about the amount she/he is eating, and then adjusting the amount of insulin being delivered by the pump based on a mathematical formula that would be very personalized to that patient.

25 Jul 2013

Combination treatment can reduce hepatitis C infection in people who inject drugs

The burden of liver disease could be dramatically reduced by scaling up the combination of interventions for hepatitis C infection among people who inject drugs according to University of Bristol researchers. The findings, published today [24 July], form part of new global recommendations on treating the virus.

25 Jul 2013

Combination of 6 comprehensive measures to prevent spread of hepatitis C

UC San Francisco researchers are recommending a combination of six comprehensive measures to prevent the spread of hepatitis C, in an effort to address the more than 31,000 young people they estimate may be newly infected with the virus each year in the United States due to injection-drug use.

25 Jul 2013

Immunization in developing countries: an interview with Dr. Jos Vandelaer, Chief of Immunization for UNICEF

Overall, worldwide, immunization programs reach around 83% of all children – this is an enormous achievement. With this level of immunization coverage, we prevent over 2 million deaths, year after year. This statistic is often forgotten or taken for granted.

11 Jul 2013

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

A new low-cost method of in-vitro fertilization developed at the University of Colorado Boulder that performed successfully in recent human clinical trials in Belgium may help thousands of infertile couples in developing countries.

9 Jul 2013

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

West Pharmaceutical Services, Inc., a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products.

2 Jul 2013

UTHealth collaborates with Rice University to save lives of CVD patients in Fiji

A device born out of a collaboration between The University of Texas Health Science Center at Houston (UTHealth) and Rice University could save lives in Fiji where cardiovascular disease has been called a pandemic.

14 Jun 2013

NACC recommendations address established pain therapies and preview potential future advances

Recommendations of the Neuromodulation Appropriateness Consensus Committee (NACC), announced at the 11th World Congress of the International Neuromodulation Society (INS), address established therapies and preview emerging and potential future advances.

13 Jun 2013

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route.

13 Jun 2013

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Anthrax vaccines have a prominent place in the history of medicine. This goes back to, Pasteur, who while everybody associates with the milk treatment process, also worked on rabies and Anthrax vaccines in cattle.

6 Jun 2013

Kerr announces launch of new Nexus RMGI dental cement

Kerr Corporation, a leading manufacturer of innovative dental restorative materials, has announced the launch of its new Nexus RMGI, a unique dental cement that combines One-Peel™ cleanup, outstanding durability, and improved esthetic qualities for consistent, predictable outcomes.

5 Jun 2013

New nano-sized needle can help study the effects of medicines on cells

Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.

24 May 2013

Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

Ambulatory pumps allow patients to continue receiving treatment or therapy away from a hospital, thereby leading a normal life during treatment. Due to the size and design of these pumps, patients can carry them around in a carry pouch.

17 May 2013

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved its New Drug Application for Nymalize (nimodipine) oral solution.

14 May 2013

Early limited formula can provide important benefits to some newborns

Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.

14 May 2013

Syringe News and Research

Study shows how stomach bacteria manipulates human immune system to survive in stomach

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Smartphone-based portable device to conduct kidney tests invented at UCLA

CSL Biotherapies starts shipment of seasonal influenza vaccine for 2013-2014 season

Scientists solve structure of infection tool used by Yersinia bacterium

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Combination treatment can reduce hepatitis C infection in people who inject drugs

Combination of 6 comprehensive measures to prevent spread of hepatitis C

Immunization in developing countries: an interview with Dr. Jos Vandelaer, Chief of Immunization for UNICEF

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

UTHealth collaborates with Rice University to save lives of CVD patients in Fiji

NACC recommendations address established pain therapies and preview potential future advances

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Kerr announces launch of new Nexus RMGI dental cement

New nano-sized needle can help study the effects of medicines on cells

Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Early limited formula can provide important benefits to some newborns

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News